These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22157020)

  • 1. Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors.
    Wakabayashi H; Taki J; Inaki A; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
    Clin Nucl Med; 2012 Jan; 37(1):1-8. PubMed ID: 22157020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
    Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
    J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early prediction of histopathological tumor response to preoperative chemotherapy by Tc-99m MIBI imaging in bone and soft tissue sarcomas.
    Taki J; Inaki A; Wakabayashi H; Sumiya H; Tsuchiya H; Zen Y; Kinuya S
    Clin Nucl Med; 2010 Mar; 35(3):154-9. PubMed ID: 20173444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
    Moustafa H; Riad R; Omar W; Zaher A; Ebied E
    Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.
    Wakabayashi H; Saito J; Taki J; Hashimoto N; Tsuchiya H; Gabata T; Kinuya S
    Skeletal Radiol; 2016 Jan; 45(1):87-95. PubMed ID: 26385785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
    J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography.
    Miwa S; Shirai T; Taki J; Sumiya H; Nishida H; Hayashi K; Takeuchi A; Ooi A; Tsuchiya H
    Int J Clin Oncol; 2011 Aug; 16(4):373-8. PubMed ID: 21331769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [²⁰¹TI and (99m)Tc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma].
    Huang ZK; Lou C; Shi GH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):183-7, 191. PubMed ID: 22499516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
    Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
    Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
    Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
    Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM
    Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.
    Song HC; Lee JJ; Bom HS; Chung IJ; Kim HJ; Park YK; Kim EE
    Clin Nucl Med; 2003 Jun; 28(6):457-62. PubMed ID: 12911092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
    J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
    Bacovsky J; Myslivecek M; Scudla V; Koranda P; Buriankova E; Minarik J; Pika T; Zapletalova J
    Clin Nucl Med; 2010 Sep; 35(9):667-70. PubMed ID: 20706038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the alteration uptake ratio of
    Huang Z; Lou C
    Hell J Nucl Med; 2018; 21(1):55-59. PubMed ID: 29705817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tc-99m MIBI to evaluate children with Ewing's sarcoma.
    Bar-Sever Z; Cohen IJ; Connolly LP; Horev G; Perri T; Treves T; Hardoff R
    Clin Nucl Med; 2000 Jun; 25(6):410-3. PubMed ID: 10836685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
    Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
    J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Double imaging" for the diagnostic work-up of alveolar soft part sarcoma with Tc-99m MIBI.
    Demir H; Berk F; Memisoglu K; Arslan A; Muezzinoglu B; Erdincler RO; Isgoren S; Sarlak A; Aktolun C
    Ann Nucl Med; 2002 Apr; 16(2):151-5. PubMed ID: 12043911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.